Clinical trials
Phase 2 Obesity trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Manhattan Pharmaceuticals | 2 |
| Augusta University | 1 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 1 |
| Central Washington University | 1 |
| Centro Universitario de Ciencias de la Salud, Mexico | 1 |
| Charite University, Berlin, Germany | 1 |
| Colorado State University | 1 |
| Empros Pharma AB | 1 |
| Federal University of Minas Gerais | 1 |
| Fondation Hôpital Saint-Joseph | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 34 |
| Overweight | 11 |
| Diabetes Mellitus, Type 2 | 7 |
| Diabetes Mellitus | 3 |
| Weight Loss | 3 |
| Atherosclerosis | 1 |
| Body Weight | 1 |
| Body Weight Changes | 1 |
| COVID-19 | 1 |
| Diabetic Nephropathies | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.